Search

Your search keyword '"Ginex, Tiziana"' showing total 157 results

Search Constraints

Start Over You searched for: Author "Ginex, Tiziana" Remove constraint Author: "Ginex, Tiziana"
157 results on '"Ginex, Tiziana"'

Search Results

1. Screening and Biological Evaluation of Soluble Epoxide Hydrolase Inhibitors: Assessing the Role of Hydrophobicity in the Pharmacophore-Guided Search of Novel Hits

3. Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria.

4. From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects

9. MBC and ECBL libraries: outstanding tools for drug discovery

10. N′-phenylacetohydrazide derivatives as potent Ebola virus entry inhibitors with an improved pharmacokinetic profile

12. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

13. N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

14. COVID-19: Drug Targets and Potential Treatments

17. Potential pharmacological strategies targeting the Niemann-Pick C1receptor and Ebola virus glycoprotein interaction

18. Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

19. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation

20. P25 Ligand and structure-based virtual screening toward identifying new potent inhibitors against SGK 1

21. P25 Ligand and structure-based virtual screening toward identifying new potent inhibitors against SGK 1

22. Searching for effective antiviral small molecules against influenza A virus: A patent review

23. Supplementary Information: The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

24. The role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation

25. Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies

27. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation.

28. Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

30. Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods

31. Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M

32. Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods

34. Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6

35. Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs

37. Synthesis, in vitro profiling, and in vivo efficacy studies of a new family of multitarget antiAlzheimer compounds

38. Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties

39. 4,4-Disubstituted N-benzylpiperidines: a novel class of fusion inhibitors of influenza virus H1N1 targeting a new binding site in hemagglutinin

40. Synthesis, in vitro profiling, and in vivo efficacy studies of a new family of multitarget anti-alzheimer compounds

42. Synthesis, In Vitro Profiling, and In Vivo Efficacy Studies of a New Family of Multitarget Anti-Alzheimer Compounds

44. Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles

45. Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties

50. Multi-scale approaches to Food Sciences: computational QM and MM explorations at the microscopic level

Catalog

Books, media, physical & digital resources